AstraZeneca opened its global headquarters and research and discovery centre at the £1billion Discovery Centre (the DISC) on ...

The $50 billion target, which AstraZeneca plans to meet by 2030, includes new manufacturing projects in Virginia and ...

The company will build a multi-billion-dollar drug manufacturing center in Virginia that will focus on chronic diseases, as ...

AstraZeneca has announced a US$50 billion investment in the United States by 2030, building on America’s global leadership in ...

The company plans to invest billions in a new drug manufacturing hub in Virginia, dedicated to chronic disease treatments, alongside additional facilities in California, Indiana, Maryland, ...

AstraZeneca has briefed councillors on their plans to build a new office and conference centre at the Cambridge Biomedical ...

The company said the Virginia facility "would be AstraZeneca’s largest single manufacturing investment in the world." The ...

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, July 28, 2025 /PRNewswire/ -- Harbour BioMed (the 'Company'; HKEX: ...

The US biopharma has planted roots in the UK’s biotech cluster as it bets on synthetic rescue to unlock new treatments for ...

The deal, which Youngkin signed on Monday, has not been reviewed by the Democrat-controlled General Assembly. The governor ...

AstraZeneca unveils a $50 billion U.S. manufacturing expansion plan, anchored by a Virginia facility to boost drug output and ...

Gov. Glenn Youngkin says he has a deal for a multi-billion-dollar pharmaceutical factory in Virginia, but he doesn't have a ...